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ABSTRACT: During the coronavirus disease 2019 (COVID-19) pandemic, the World Health Organization recommended 
measures to mitigate the outbreak such as social distancing and confinement. Since these measures have been put in place, 
anecdotal reports describe a decrease in the number of endovascular therapy (EVT) treatments for acute ischemic stroke 
due to large vessel occlusion. The purpose of our study was to determine the effect on EVT for patients with acute ischemic 
stroke during the COVID-19 confinement. In this retrospective, observational study, data were collected from November 1, 
2019, to April 15, 2020, at 17 stroke centers in countries where confinement measures have been in place since March 
2020 for the COVID-19 pandemic (Switzerland, Italy, France, Spain, Portugal, Germany, Canada, and United States). This study 
included 1600 patients treated by EVT for acute ischemic stroke. Date of EVT and symptom onset-to-groin puncture time 
were collected. Mean number of EVTs performed per hospital per 2-week interval and mean stroke onset-to-groin puncture 
time were calculated before confinement measures and after confinement measures. Distributions (non-normal) between the 
2 groups (before COVID-19 confinement versus after COVID-19 confinement) were compared using 2-sample Wilcoxon 
rank-sum test. The results show a significant decrease in mean number of EVTs performed per hospital per 2-week interval 
between before COVID-19 confinement (9.0 [95% CI, 7.8–10.1]) and after COVID-19 confinement (6.1 [95% CI, 4.5–7.7]), 
(P<0.001). In addition, there is a significant increase in mean stroke onset-to-groin puncture time (P<0.001), between before 
COVID-19 confinement (300.3 minutes [95% CI, 285.3–315.4]) and after COVID-19 confinement (354.5 minutes [95% CI, 
316.2–392.7]). Our preliminary analysis indicates a 32% reduction in EVT procedures and an estimated 54-minute increase 
in symptom onset-to-groin puncture time after confinement measures for COVID-19 pandemic were put into place.
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The coronavirus disease 2019 (COVID-19) pan-demic is having an enormous impact on the health-care system worldwide directly and indirectly. To 
mitigate the increasing number of patients with COVID-
19, the World Health Organization recommends apply-
ing reactive measures to the general public such as 
stopping all nonessential services, practicing social 
distancing, and confining individuals to their homes 
with the goal of reducing person-to-person contact 
and, therefore, decreasing viral spread.1 Stroke due to 
large vessel occlusion is a neurological emergency and 
is, fortunately, most oftentimes detected during person-
to-person interactions.2 These interactions facilitate 
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meet the criteria for endovascular therapy (EVT), the 
standard of care for large vessel occlusion-related 
patients with stroke.3 The American Stroke Association, 
European Stroke Organization, and European Society 
of Minimally Invasive Neurological Therapy recommend 
prompt EVT during the current pandemic because of 
the high mortality rate and severe neurological dis-
ability in untreated patients.4,5 Unfortunately, reports 
suggest a decrease in the number of EVTs during the 
pandemic, reportedly a 25.3% decrease in China and 
a 21% decrease in France compared the number of 
EVTs performed before the COVID-19 pandemic, which 
may be explained by patients’ ineligibility for EVT due to 
increased delays from stroke onset to treatment.6,7
We sought to determine whether there has been a sig-
nificant decrease in number of EVTs performed for stroke 
treatment, in addition to a possible increase in stroke 
onset-to-groin puncture time. The study design, raw data, 
statistical analysis, and any related materials are avail-
able by request to the first author (Dr Hajdu). The insti-
tutional review board at each participating site approved 
analysis and publication of anonymized and retrospec-
tively obtained data. Informed consent was not required.
We analyzed consecutive EVT procedures performed 
in 17 stroke centers from November 11, 2019, to April 
15, 2020. Among the participating centers, 6 were based 
in France, 3 in Portugal, 2 in Italy, 2 in Switzerland, 1 in 
Spain, 1 in Germany, 1 in Canada, and 1 in the United 
States with an annual mean EVT case load of 187 ([95% 
CI, 159–215]; min: 96; max: 334).
Among the centers included in this study, 1600 EVT 
procedures were available for analysis of which 776 had 
data on stroke onset-to-groin puncture time. Despite the 
limitation of the latter being available in approximately 
half of our cohort, we possessed a sufficiently large 
amount of observations for a robust onset-to-groin punc-
ture time analysis. Official confinement dates were iden-
tified for each country varying from March 9, 2020, in 
Italy to March 23, 2020, in Ontario, Canada. Then based 
on these dates, 2 periods were established accordingly 
as before COVID-19 confinement when social life and 
medical operations were functioning normally and after 
COVID-19 confinement when government restrictions, 
social distancing, and confinement were applied.
We calculated (1) mean number of EVTs performed 
and (2) mean stroke onset-to-groin puncture time inter-
val (minutes) per hospital and per 2-week interval.
For descriptive purpose, we reported mean number of 
EVTs performed per hospital per 2-week interval, which 
Nonstandard Abbreviations and Acronyms
EVT endovascular therapy
COVID-19 coronavirus disease 2019
Figure. Endovascular therapy (EVT) for stroke before and after coronavirus disease 2019 (COVID-19) confinement measures.
A, Visual representation of mean number of EVT cases for stroke per hospital per 2-wk period and number of confirmed COVID-19 cases in 
Switzerland, France, Italy, Germany, Spain, Portugal, Canada, and the United States from November 1, 2019 to April 15, 2020. B, Mean number of 
EVTs for stroke per hospital per 2-wk period and (C) mean stroke onset-to-groin puncture time before and after COVID-19 confinement.
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ranged between 6.4 and 10.4 with a 4-week moving 
average that globally declined with time (Figure [A]). 
We then compared distributions (non-normal) between 
the 2 groups (before COVID-19 confinement versus 
after COVID-19 confinement) using 2-sample Wilcoxon 
rank-sum tests.
The results showed a significant decrease in mean 
number of EVTs performed per hospital per 2-week inter-
val between before COVID-19 confinement (9.0 [95% 
CI, 7.8–10.1]) and after COVID-19 confinement (6.1 
[95% CI, 4.5–7.7]), (P<0.001; Figure [B]). Additionally, we 
observed a significant increase in mean stroke onset-to-
groin puncture time (P<0.001), between before COVID-
19 confinement (300.3 minutes [95% CI, 285.3–315.4]) 
and after COVID-19 confinement (354.5 minutes [95% 
CI, 316.2–392.7]; Figure [C]).
Interestingly, many physicians involved in stroke man-
agement would have predicted an increase in the number 
of acute ischemic strokes and thus EVT due to the known 
risk of viral-induced hypercoagulable states and reports 
on cardiovascular complications related to COVID-19.8 
Critically ill patients with COVID-19 have been reported 
to suffer from a remarkably high rate of thrombotic dis-
ease.9,10 Paradoxically, our analysis shows an estimated 
32% reduction in EVT procedures and an estimated 
54-minute increase in symptom onset-to-groin puncture 
time after confinement measures were put into place. This 
is similar to the data regarding the reduction of emergency 
cardiac catheterizations in the United States, Spain, and 
Italy.11–13 While a more comprehensive report using data 
from additional stroke centers with corresponding regional 
analyses is warranted, we hypothesize that decreased 
person-to-person contact due to social distancing has 
led to a decrease in stroke admission and thus a drop 
in EVT, while delayed stroke recognition has led to an 
increase in prehospital delay time. These effects would 
lead to an increase in stroke-related morbidity and mortal-
ity and, therefore, an unfortunate indirect consequence of 
the reactive measures promoted by health organizations 
during the pandemic. While more studies are required to 
confirm our findings, national health organizations and the 
World Health Organization should be alerted to this trend 
and COVID-19 related recommendations in the meantime 
should consider integrating strategies for medical emer-
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